SCHEMBL6992502

SCHEMBL6992502

C=C(C)Cn1c(=O)n(C)c(=O)c2c[nH]nc21

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 1/20 0.45
MAPK1 P28482 1/20 0.42
KMT2A Q03164 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HTT P42858 1/20 0.40
POLB P06746 1/20 0.36
TSHR P16473 2/20 0.36
MEN1 O00255 1/20 0.35
ATM Q13315 1/20 0.35
ADORA2B P29275 2/20 0.35
PDE4A P27815 3/20 0.34
PDE4B Q07343 3/20 0.34
PDE4C Q08493 3/20 0.34
PDE4D Q08499 3/20 0.34
KDM4E B2RXH2 1/20 0.34
ADORA2A P29274 2/20 0.34
ALDH1A1 P00352 1/20 0.34
HSD17B10 Q99714 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11193538 0.81 ADORA2A (0.51) MAPK1HTTTSHRADORA2BPDE4A
SCHEMBL5403546 0.78 PDE5A (0.45) PDE5AMAPK1SMN1; SMN2POLBADORA2B
SCHEMBL10991845 0.77 PDE4A (0.51) MAPK1SMN1; SMN2TSHRADORA2BPDE4A
SCHEMBL675547 0.77 PDE5A (0.43) PDE5AADORA2BPDE4APDE4BPDE4C
SCHEMBL5410997 0.77 PDE1A (0.55) PDE5AMAPK1KMT2ATSHRMEN1
SCHEMBL10988778 0.75 ADORA2A (0.49) MAPK1KMT2ASMN1; SMN2HTTTSHR
SCHEMBL11185750 0.74 PDE4A (0.37) KMT2ASMN1; SMN2TSHRMEN1ADORA2B
SCHEMBL4623469 0.72 PDE4A (0.68) PDE5AMAPK1TSHRADORA2BPDE4A
SCHEMBL7458328 0.71 ALDH1A1 (0.50) MAPK1KMT2APOLBTSHRMEN1
SCHEMBL3665761 0.70 HPGD (0.52) KMT2ASMN1; SMN2HTTPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0975636-B1 1H-PYRAZOLO[3,4-D]PYRIMIDINE-4,6-DIONES AS T-CELL PROLIFERATION INHIBITORS ASTRAZENECA AB (SE) 2003-07-23 EP disclosed
US-6028074-A FOR TREATING ALLOGRAFT REJECTION ASTRA PHARMACEUTICALS, LTD. (GB) 2000-02-22 US disclosed
EP-0975636-A1 NOVEL COMPOUNDS Astra Pharmaceuticals Limited (GB) 2000-02-02 EP disclosed
WO-1998046606-A1 NOVEL COMPOUNDS ASTRA PHARMACEUTICALS LTD. (GB) 1998-10-22 WO disclosed